CTI BioPharma is headquartered in Seattle, Washington.
CTI BioPharma disclosed revenue of 54M USD for 2022 and 3M USD for 2019.
CTI BioPharma has 144 employees.
CTI BioPharma is a life science company.
CTI BioPharma was founded in 1991.
3101 Western Avenue, Suite 800,
Seattle, Washington
98121
United States,
(206) 282-7100
www.ctibiopharma.com
CTI is a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. CTI BioPharma was founded in 1991 and is based in Seattle, Washington.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| Sell (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
